Regeneron Pharmaceuticals Archives - DelveInsight

Regeneron Pharmaceuticals

dupixent-market
Can Dupixent Be A Gamechanger In The Atopic Dermatitis Treatment Landscape?

Dupixent (dupilumab) is a non-immunosuppressive fully human monoclonal antibody that inhibits the signalling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins. According to data from...


Sinusitis-Disease-Overview-Signs-and-Treatments
Sinusitis: Something More Troublesome Than Just Cold

Cold can make anyone cheerless and miserable, however, having Sinusitis is another story. Also known as rhinosinusitis, Sinusitis makes a person suffer from a stuffy nose, blocked nasal passages, ...


Latest Pharma Happenings
Regeneron’s cocktail antibody, REGN-COV2; J&J’s manufacturing-spree; ObsEva̵...

Regeneron Pharmaceuticals launches the Phase III trials of REGN-COV2 for treatment and prevention of COVID-19.   Regeneron is running two trials simultaneously, one for prevention and oth...


pharma news
Sage seeks to save depression drug; Regeneron aims clinical trial; J&J sets sights for COVI...

Sage Therapeutics seeking out to save flunked depression drug  Sage Therapeutics has strategized on how to come back from the phase 3 failure of SAGE-217 in major depressive disorder. The ...


Pharma News
Immune cells for age-related diseases; Regeneron’s antibody for 2019-nCoV; FDA nods for hy...

Activated immune cells responsible for improving age-related diseases  The main culprits of the inflammatory responses associated with asthma are Interleukins IL-33 and IL-5. There has been res...


Allergic rhinitis market
Allergic rhinitis market: How common is Hay fever?

Allergic diseases, such as allergic rhinitis (hay fever), food allergy, and eczema, are common allergies that affect people from all over the world. As per CDC, allergies are one of the top ten ca...


World Pharma News
Sanifit nets USD 80.9 M; FDA approves Dupixent for CRS; AbbVie buys Allergan

Sanifit raises USD 80.9 M to advance Calciphylaxis Pipeline Sanifit, a clinical-stage biopharmaceutical company, has raised USD 80.9 million ( €72.2 million ) in total private fundraising. The ...


Notizia

Anylam, Regeneron to broaden the scope of R&D in Pharma Alnylam in collaboration with Regeneron is expanding its research on NASH. Regeneron with the capability of generating various target...


SANOFI
Cholesterol drug Praluent successful in reducing heart risk

Sanofi and Regeneron Pharmaceuticals got effective results in reducing the risk of major adverse heart events in a clinical study of nearly 19,000 patients with the help of cholesterol drug Praluen...


Prosecutors rope Pfizer; Pharma groups to FDA; Regeneron simulates; Otsuka & Lundbeck revive...

Prosecutors rope Pfizer into fast-growing copay assistance probe After first focusing on biotech and speciality pharma, the feds have made their way to Big Pharma, with the New York drug giant join...


Editor's Pick
Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU ...

Patent protection and expiration is one of the hot topics in the healthcare industry. P...

What are the Top 9 Most Common Food Allergies and How Pharma Companies are Ta...

Food Allergies is a major concern for a wide spectrum of populations globally. Accordin...

Evaluating the Top Players in the Global Bone Densitometers Market

Bone densitometers are the diagnostic systems with an enhanced X-ray technology known a...

Mapping the Biggest Pharmaceutical Companies by Continents

Today, the most important factor affecting the world’s economy is the Global Pharmaceut...

Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Develop...

It's no longer startling to learn that the best-performing surgeon at a hospital isn't ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.